BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6411378)

  • 21. Modification of aflatoxin B1 biotransformation in vitro and DNA binding in vivo by dietary broccoli in rats.
    Ramsdell HS; Eaton DL
    J Toxicol Environ Health; 1988; 25(3):269-84. PubMed ID: 3141626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of the principal aflatoxin B1-DNA adduct formed in vivo in rat liver.
    Croy RG; Essigmann JM; Reinhold VN; Wogan GN
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1745-9. PubMed ID: 273905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural characterization of the major adducts obtained after reaction of an ultimate carcinogen aflatoxin B1-dichloride with calf thymus DNA in vitro.
    Wood ML; Smith JR; Garner RC
    Cancer Res; 1988 Oct; 48(19):5391-6. PubMed ID: 3138022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dietary modulation of the biotransformation and genotoxicity of aflatoxin B(1).
    Gross-Steinmeyer K; Eaton DL
    Toxicology; 2012 Sep; 299(2-3):69-79. PubMed ID: 22640941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aflatoxin metabolism in humans: detection of metabolites and nucleic acid adducts in urine by affinity chromatography.
    Groopman JD; Donahue PR; Zhu JQ; Chen JS; Wogan GN
    Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6492-6. PubMed ID: 3931076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutational properties of the primary aflatoxin B1-DNA adduct.
    Bailey EA; Iyer RS; Stone MP; Harris TM; Essigmann JM
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1535-9. PubMed ID: 8643667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative formation and removal of aflatoxin B1-DNA adducts in cultured mammalian tracheal epithelium.
    Ball RW; Wilson DW; Coulombe RA
    Cancer Res; 1990 Aug; 50(16):4918-22. PubMed ID: 2116221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of aflatoxin and aflatoxin metabolites in urine by liquid chromatography-tandem mass spectrometry.
    Everley RA; Ciner FL; Zhan D; Scholl PF; Groopman JD; Croley TR
    J Anal Toxicol; 2007 Apr; 31(3):150-6. PubMed ID: 17579962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aflatoxin B1 carcinogenesis and its relation to DNA adduct formation and adduct persistence in sensitive and resistant salmonid fish.
    Bailey GS; Williams DE; Wilcox JS; Loveland PM; Coulombe RA; Hendricks JD
    Carcinogenesis; 1988 Nov; 9(11):1919-26. PubMed ID: 3141073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary aflatoxins and human liver cancer. A study in Swaziland.
    Peers FG; Gilman GA; Linsell CA
    Int J Cancer; 1976 Feb; 17(2):167-76. PubMed ID: 1248903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4.
    Gallagher EP; Kunze KL; Stapleton PL; Eaton DL
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China.
    Groopman JD; Zhu JQ; Donahue PR; Pikul A; Zhang LS; Chen JS; Wogan GN
    Cancer Res; 1992 Jan; 52(1):45-52. PubMed ID: 1727385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorescence quantification of aflatoxin N7-guanine adducts.
    Weaver VM; Groopman JD
    Cancer Epidemiol Biomarkers Prev; 1994 Dec; 3(8):669-74. PubMed ID: 7881340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of aflatoxin B(1)-lysine adduct monoclonal antibody for human exposure studies.
    Wang JS; Abubaker S; He X; Sun G; Strickland PT; Groopman JD
    Appl Environ Microbiol; 2001 Jun; 67(6):2712-7. PubMed ID: 11375185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aflatoxin B1 formamidopyrimidine adducts are preferentially repaired by the nucleotide excision repair pathway in vivo.
    Alekseyev YO; Hamm ML; Essigmann JM
    Carcinogenesis; 2004 Jun; 25(6):1045-51. PubMed ID: 14742311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer.
    Egner PA; Wang JB; Zhu YR; Zhang BC; Wu Y; Zhang QN; Qian GS; Kuang SY; Gange SJ; Jacobson LP; Helzlsouer KJ; Bailey GS; Groopman JD; Kensler TW
    Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14601-6. PubMed ID: 11724948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of phenobarbital on the biliary excretion of aflatoxin P1-glucuronide and aflatoxin B1-S-glutathione in the rat.
    Holeski CJ; Eaton DL; Monroe DH; Bellamy GM
    Xenobiotica; 1987 Feb; 17(2):139-53. PubMed ID: 3105186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-affinity monoclonal antibodies for aflatoxins and their application to solid-phase immunoassays.
    Groopman JD; Trudel LJ; Donahue PR; Marshak-Rothstein A; Wogan GN
    Proc Natl Acad Sci U S A; 1984 Dec; 81(24):7728-31. PubMed ID: 6440143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The formation of AFB(1)-macromolecular adducts in rats and humans at dietary levels of exposure.
    Cupid BC; Lightfoot TJ; Russell D; Gant SJ; Turner PC; Dingley KH; Curtis KD; Leveson SH; Turteltaub KW; Garner RC
    Food Chem Toxicol; 2004 Apr; 42(4):559-69. PubMed ID: 15019179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thermal stabilization of the DNA duplex by adducts of aflatoxin B1.
    Giri I; Stone MP
    Biopolymers; 2002 Nov; 65(3):190-201. PubMed ID: 12228924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.